Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06406452
NA

Bioresorbable Airway Splint Pivotal Clinical Trial

Sponsor: University of Michigan

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn if a three-dimensional (3D) printed airway splint device made to hold open a collapsing airway is a safe and effective treatment of Tracheobronchomalacia (TBM) in children. The airway splint is bioresorbable, meaning the child's body will absorb the splint over about five years.

Official title: A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia

Key Details

Gender

All

Age Range

1 Week - 3 Years

Study Type

INTERVENTIONAL

Enrollment

35

Start Date

2025-01-07

Completion Date

2034-03

Last Updated

2026-01-21

Healthy Volunteers

No

Interventions

DEVICE

Bioresorbable Tracheobronchial Splint

Subjects will have several imaging and bronchoscopic studies and the placement of the splint will require an open-chest surgery to implant the airway splint (s). The Materialise Bioresorbable Tracheobronchial Splint is designed for an individual subject based on Computed Tomography (CT) scans taken using a specific scan protocol. Based on these 3D models, a pre-operative plan is discussed between the Materialise engineering team and the treating surgeon(s) to determine the locations and required dimensions of the splint(s). Each subject may receive up to four splints positioned on subject's trachea or mainstem bronchi. Subjects will also have several follow-up visits, and parents will be expected to regularly fill out questionnaires.

Locations (1)

University of Michigan

Ann Arbor, Michigan, United States